Skip to main content
. 2021 Nov 3;8(1):e001003. doi: 10.1136/bmjresp-2021-001003

Figure 1.

Figure 1

Identification and characterisation of new initiators of mepolizumab. Among adult patients identified with National Drug Codes (NDCs) in dispensing of medical claims files, 11% also had a procedure code in the medical claim file. COPD, chronic obstructive pulmonary disease.